Minting Millions from the Magic Molecule

By alaska51, May 16, 2013

This is a teaser from Nick Hodges Early Advantage advisory. He is promoting the stock of a company that has a salt water farm where they grow Keyhole limpets or sea snails. The claim is that the blood of these creatures is very rare and commands extremely high prices, especially from big pharmaceutical companies. He claims that the development of some cancer fighting drugs is dependent upon the blood of these creatures. You can read the rest of his pitch in the teaser. What do ya think Travis?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

Share your thoughts...

4 Comments on " Minting Millions from the Magic Molecule"

Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Travis Johnson, Stock Gumshoe

Haven’t seen it yet, but from your description it sounds delightfully odd. I’ll have to look for it. Harvesting the blood of sea snails would be a first for me.

Travis Johnson, Stock Gumshoe

Looks quite likely that it’s these guys, Stellar Biotechnologies (SBOTF, thinly traded over the counter and very small) though I’ve done no more than take a cursory look:

The stock spurted up on big volume for some reason in February, that could have been a newsletter recco (or real news, I suppose).


I purchased this stock @ .63 and i am up 54% as of 7/19


There are a number of “Investment Gures” that will sell you the name of the company that supplies the BLUE BLOOD PROTIEN from $49 to $149. They call it “FREE Information”.